APA (7th ed.) Citation

Lee, Y. J., Park, Y. S., Lee, H. W., Park, T. Y., Lee, J. K., & Heo, E. Y. (2022). Peripheral lymphocyte count as a surrogate marker of immune checkpoint inhibitor therapy outcomes in patients with non-small-cell lung cancer. Scientific Reports, 12(1), 1. https://doi.org/10.1038/s41598-021-04630-9

Chicago Style (17th ed.) Citation

Lee, Ye Jin, Young Sik Park, Hyun Woo Lee, Tae Yoen Park, Jung Kyu Lee, and Eun Young Heo. "Peripheral Lymphocyte Count as a Surrogate Marker of Immune Checkpoint Inhibitor Therapy Outcomes in Patients with Non-small-cell Lung Cancer." Scientific Reports 12, no. 1 (2022): 1. https://doi.org/10.1038/s41598-021-04630-9.

MLA (9th ed.) Citation

Lee, Ye Jin, et al. "Peripheral Lymphocyte Count as a Surrogate Marker of Immune Checkpoint Inhibitor Therapy Outcomes in Patients with Non-small-cell Lung Cancer." Scientific Reports, vol. 12, no. 1, 2022, p. 1, https://doi.org/10.1038/s41598-021-04630-9.